The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Gary Steinberg Stock and Other Ownership Interests - CG Oncology Consulting or Advisory Role - CG Oncology Research Funding - CG Oncology   Roger Li Stock and Other Ownership Interests - Beam Therapeutics; CRISPR therapeutics; Intellia Therapeutics; Lilly Honoraria - IBCG; MashupMD; UroToday Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson/Janssen; Merck; Pfizer; Photocure; Urogen pharma; Valar Labs Speakers' Bureau - Johnson & Johnson/Janssen Research Funding - CG Oncology; Predicine; Valar Labs Travel, Accommodations, Expenses - CG Oncology; Predicine Other Relationship - Predicine   Shreyas Joshi Consulting or Advisory Role - enGene   Trinity Bivalacqua Honoraria - Ferring; Janssen; UROGENE Consulting or Advisory Role - Urogen pharma   Mark Tyson Consulting or Advisory Role - AstraZeneca; enGene; Ferring; ImmunityBio; Protara Therapeutics Research Funding - AstraZeneca (Inst); CG Oncology (Inst); enGene (Inst); Ferring (Inst); ImmunityBio (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); NCI (Inst); pacific edge (Inst); Protara Therapeutics (Inst); Seagen (Inst); SWOG (Inst); Urogen pharma (Inst)